Source link : https://www.newshealth.biz/health-news/alzheimers-gets-new-galantamine-drug/
The FDA approved oral benzgalantamine (Zunveyl) to treat symptoms of mild-to-moderate Alzheimer’s disease, Alpha Cognition announced on Monday. A prodrug of galantamine and an acetylcholinesterase inhibitor (AChEI), benzgalantamine has a dual mechanism of action designed to eliminate drug absorption in the gastrointestinal (GI) tract and potentially improve tolerability. Galantamine was approved in 2001 as Razadyne […]
Author : News Health
Publish date : 2024-07-30 19:10:15
Copyright for syndicated content belongs to the linked Source.